Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) [Phase 2]
This Phase 2 trial from the University of Manitoba is evaluating antibiotic prophylaxis in patients with myelodysplastic syndrome and acute …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms [Phase 1]
This clinical trial update announces a Phase 1 study of JNJ-88549968 for CALR-mutated myeloproliferative neoplasms and indicates the trial i…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers [Phase 1]
ZE74-0282 is the subject of a Phase 1 trial for JAK2 V617F-positive blood cancers, including polycythemia vera and myelofibrosis, and the st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) [Phase 2]
A Phase 2 randomized trial evaluating ASTX727 with or without iadademstat in advanced myeloproliferative neoplasms, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia [NA]
The ENERGIA study tests a personalized exercise program to reduce fatigue in patients with myeloproliferative neoplasms and chronic myeloid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) [Phase 3]
Phase 3 study of bomedemstat (MK-3543-017) sponsored by Merck is currently recruiting to evaluate safety and efficacy in essential thrombocy…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms [Phase 1]
Phase 1 study of PRT12396 in select myeloproliferative neoplasms is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera [Phase 3]
Phase 3 clinical trial comparing givinostat to hydroxyurea in patients with polycythemia vera is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms [Phase 3]
Phase 3 clinical trial AVAJAK compares apixaban or rivaroxaban with aspirin for primary prevention of thromboembolic events in patients with…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms [Phase 2]
A Phase 2 clinical trial evaluating decitabine in combination with JAK inhibitors (ruxolitinib, fedratinib, or pacritinib) for accelerated o…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms [Phase 1, Phase 2]
This clinical trial aims to identify the optimal dose of N-acetylcysteine in patients with myeloproliferative neoplasms. It spans Phase 1/2 …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
A clinical trial update focused on identifying factors associated with treatment response in patients with polycythemia vera, essential thro…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) [Phase 2]
Phase 2 open-label study of DISC-3405 in participants with polycythemia vera is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV [NA]
Clinical study evaluating Gecacitinib combined with Pegylated Interferon in Polycythemia Vera; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) [Phase 3]
This clinical trial update describes a Phase 3 study of Sapablursen evaluating safety and efficacy in participants with Polycythemia vera, w…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
This entry describes the MPN PROGRESSion Registry, an observational study to track symptoms, treatments, and disease progression in people w…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera [NA]
A clinical trial update from Hospices Civils de Lyon describes a study investigating biological and physiological determinants of exercise i…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis [Phase 2]
Phase 2 clinical trial evaluating elotuzumab for JAK2-mutated myelofibrosis; the study is active but not recruiting and includes myelofibros…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
A clinical trial evaluating Ropeginterferon Alfa-2b for polycythemia vera patients without symptomatic splenomegaly is currently recruiting.…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) [Phase 2]
Phase 2 clinical trial update for IMG-7289 in essential thrombocythemia and polycythemia vera; the study is currently active but not recruit…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
This is an observational update on ropeginterferon alfa-2b for polycythemia vera; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
A multicenter ELN study investigating phenotypic evolution and clinical outcomes in polycythemia vera and thrombocythemia is currently recru…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: LOW-PV Continuation
The LOW-PV Continuation trial (NCT06752941) sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS is currently recruiting fo…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study to Assess SLN124 in Patients With Polycythemia Vera [Phase 1, Phase 2]
Clinical trial update for SLN124 in Polycythemia vera reports ongoing Phase 1/Phase 2 evaluation. The study is currently active but not recr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial [Phase 2]
A Phase 2 clinical trial called TREATMORE evaluating MethoTRExATE in myeloproliferative neoplasms is currently recruiting for polycythemia v…